Our partner is focused on developing next-generation therapies using their peptide technology. Their innovative approach targets specific disease-causing proteins, particularly in cancer, to deliver more effective and precise treatments, aiming to improve patient outcomes.

This influential hire provided development and scientific leadership to programs across the portfolio aimed at developing several highly novel peptide therapeutics. They worked closely with the Head of Clinical Development as well as clinical, translational, discovery and preclinical groups to facilitate early phase studies and development planning. This hire also collaborated with study sites, investigators, advisors and contract research organizations.